Alzheimer's disease
Samsung Invests $10M in Alzheimer's Dx Firm C2N Diagnostics
St. Louis-based C2N said it will use the funds to scale its clinical laboratory services and Alzheimer's testing capabilities.
Beckman Coulter Life Sciences, T-NeuroDx Collaborate on Early Alzheimer's Diagnostics
The collaboration will combine T-NeuroDx's research in Alzheimer's diagnostics with Beckman Coulter's flow cytometry products.
Neurology Blood Tests Primed to Improve Diagnosis, Management of Patients in Alzheimer's and Beyond
Premium
Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic mainstream.
C2N Diagnostics Receives UK Approval for PrecivityAD2 Alzheimer's Blood Test
The UK's Medicines and Healthcare products Regulatory Agency is the first regulatory agency globally to approve PrecivityAD2 as an in vitro diagnostic.
C2N Wins $1.5M Grant From Michael J Fox Foundation to Study Links Between Neurodegenerative Diseases
The firm will use its blood-based tests to explore connections between Alzheimer's disease and neuronal α-synuclein conditions including Parkinson's disease.